Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency
Breast cancer is a prevalent tumor and causes deadly metastatic complications. Myriad cancer types, including breast cancer, are effectively treated by methotrexate (MTX). However, MTX hydrophobicity, adverse effects and the development of resistance have inspired a search for new effective strategi...
Main Authors: | Amira Mansour, Mohamed Y. Mahmoud, Alaa F. Bakr, Monira G. Ghoniem, Fatima A. Adam, Ibrahim M. El-Sherbiny |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/12/2668 |
Similar Items
-
Bioenhancers: Revolutionary concept to market
by: Navin Atal, et al.
Published: (2010-01-01) -
Comparative pharmacokinetics of oxyresveratrol alone and in combination with piperine as a bioenhancer in rats
by: Dhirarin Junsaeng, et al.
Published: (2019-09-01) -
Pharmacological influences of natural products as bioenhancers of silymarin against carbon tetrachloride-induced hepatotoxicity in rats
by: Shamama Javed, et al.
Published: (2018-07-01) -
The Therapeutic Effect of Methotrexate-Conjugated Pluronic-Based Polymeric Micelles on the Folate Receptor-Rich Tumors Treatment [Retraction]
by: Chen Y, et al.
Published: (2022-11-01) -
Correction: Mansour et al. Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency. <i>Pharmaceutics</i> 2022, <i>14</i>, 2668
by: Amira Mansour, et al.
Published: (2023-03-01)